Long-Term Results of Photodynamic Therapy for Choroidal Neovascularization in Pediatric Patients with Best Vitelliform Macular Dystrophy

2015 ◽  
Vol 36 (2) ◽  
pp. 168-174 ◽  
Author(s):  
Andrea Sodi ◽  
Vittoria Murro ◽  
Orsola Caporossi ◽  
Ilaria Passerini ◽  
Giacomo Maria Bacci ◽  
...  
Retina ◽  
2012 ◽  
Vol 32 (8) ◽  
pp. 1547-1552 ◽  
Author(s):  
Fabrizio Giansanti ◽  
Gianni Virgili ◽  
Maria Carla Donati ◽  
Matteo Giuntoli ◽  
Giulia Pieretti ◽  
...  

2011 ◽  
Vol 151 (1) ◽  
pp. 137-147.e1 ◽  
Author(s):  
Kengo Hayashi ◽  
Kyoko Ohno-Matsui ◽  
Noriaki Shimada ◽  
Muka Moriyama ◽  
Wakako Hayashi ◽  
...  

Author(s):  
Elkhoyaali A ◽  
◽  
Jeddou I ◽  
Zerrouk R ◽  
Khanaouchi N ◽  
...  

A 15-year-old child followed for Best vitelliform macular dystrophy presented to the clinic with an abrupt visual impairment of his left eye. Fundus examination showed bilateral vitelliform lesions, with serous retinal detachment and adjacent retinal hemorrhage in the left eye. Fluorescein angiography and optical coherence tomography confirmed the diagnosis of type-2 choroidal neovascularization complicating the Best disease. The juxtafoveal location of the choroidal neovascularization prompted us to realize monthly intra-vitreous injections of bevacizumab. After the fourth injection, we observed visual and anatomical improvement that remained stable after a 12-month follow-up. It’s important to look for complications in front of a sudden decrease in visual acuity in Best disease.


Retina ◽  
2011 ◽  
Vol 31 (5) ◽  
pp. 959-966 ◽  
Author(s):  
Giuseppe Querques ◽  
Karim Atmani ◽  
Rislie Bouzitou-Mfoumou ◽  
Nicolas Leveziel ◽  
Nathalie Massamba ◽  
...  

2017 ◽  
Vol 16 (3) ◽  
pp. e2089-e2090
Author(s):  
V. Pierrard ◽  
S. Lebdai ◽  
J.E. Terrier ◽  
A.-R. Azzouzi ◽  
F. Kleinclauss ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document